Success Metrics

Clinical Success Rate
94.0%

Based on 313 completed trials

Completion Rate
94%(313/333)
Active Trials
18(4%)
Results Posted
22%(70 trials)
Terminated
20(5%)

Phase Distribution

Ph early_phase_1
5
1%
Ph not_applicable
19
5%
Ph phase_4
83
20%
Ph phase_1
171
42%
Ph phase_2
48
12%
Ph phase_3
74
18%

Phase Distribution

176

Early Stage

48

Mid Stage

157

Late Stage

Phase Distribution400 total trials
Early Phase 1First-in-human
5(1.3%)
Phase 1Safety & dosage
171(42.8%)
Phase 2Efficacy & side effects
48(12.0%)
Phase 3Large-scale testing
74(18.5%)
Phase 4Post-market surveillance
83(20.8%)
N/ANon-phased studies
19(4.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

91.8%

313 of 341 finished

Non-Completion Rate

8.2%

28 ended early

Currently Active

18

trials recruiting

Total Trials

409

all time

Status Distribution
Active(27)
Completed(313)
Terminated(28)
Other(41)

Detailed Status

Completed313
unknown41
Terminated20
Recruiting14
Withdrawn8
Not yet recruiting8

Development Timeline

Analytics

Development Status

Total Trials
409
Active
18
Success Rate
94.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 15 (1.3%)
Phase 1171 (42.8%)
Phase 248 (12.0%)
Phase 374 (18.5%)
Phase 483 (20.8%)
N/A19 (4.8%)

Trials by Status

recruiting143%
enrolling_by_invitation10%
active_not_recruiting41%
terminated205%
withdrawn82%
completed31377%
not_yet_recruiting82%
unknown4110%

Recent Activity

Clinical Trials (409)

Showing 20 of 409 trialsScroll for more
NCT07446400Phase 1

A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone, Metformin,Carbamazepine, Rosuvastatin, and Methotrexate When Administered Together

Recruiting
NCT07568574Not Applicable

Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite Athletes

Enrolling By Invitation
NCT07222098Phase 1

A Clinical Study of Calderasib (MK-1084) With Rosuvastatin and Metformin in Healthy People (MK-1084-016)

Completed
NCT05850091Phase 4

Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Intervention With Statin and Colchicine

Recruiting
NCT06982131Phase 1

A Study Investigating the Safety of RO7795081 and the Effect of RO7795081 on How the Body Processes Pitavastatin and Rosuvastatin in Otherwise Healthy Overweight or Obese Adult Participants

Recruiting
NCT07216482Phase 3

A Clinical Study of Enlicitide in Participants With High Cholesterol (MK-0616-037)

Recruiting
NCT03511118

Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants

Recruiting
NCT07218900Phase 2

A Study to Investigate the Effect of AZD0780 Tablets in Combination With Rosuvastatin Tablets on Low Density Lipoprotein Cholesterol Levels (LDL-C) in Adult Participants With Dyslipidaemia

Recruiting
NCT07534592Phase 1

A Study to Investigate the Effect of Elecoglipron on Rosuvastatin and Atorvastatin in Healthy Participants

Not Yet Recruiting
NCT02592317Phase 1

A Study to Evaluate the Effect of Multiple Doses of JNJ-56021927 on the Pharmacokinetics of Multiple Cytochrome P450 and Transporter Substrates in Participants With Castration-Resistant Prostate Cancer

Active Not Recruiting
NCT05483010Phase 2

Statins in Patients With Clonal Cytopenia of Undetermined Significance (CCUS) and Myelodysplastic Syndromes (MDS)

Recruiting
NCT07349394Phase 1

Effect of Vanzacaftor/Tezacaftor/Deutivacaftor (VNZ/TEZ/D-IVA) on the PK of Rosuvastatin in Healthy Participants

Completed
NCT07223671Phase 1

Study to Evaluate the Effect of Repotrectinib on the Drug Levels of Transporter and CYP P450 Probe Substrates in Healthy Adult Participants

Completed
NCT06899061Phase 1

Modular Clinical Pharmacology Study to Evaluate the Drug-drug Interaction Potential and Relative Bioavailability of Saruparib

Active Not Recruiting
NCT07431866Phase 1

A Clinical Study of the Effect of MK-2828 on Rosuvastatin or Furosemide in Healthy People (MK-2828-005)

Recruiting
NCT07474649Phase 3

A Study of Bempedoic Acid/Ezetimibe/High-intensity Statin in Patients Without Cardiovascular Events

Not Yet Recruiting
NCT07300280Phase 1

A Clinical Trial of Enlicitide and Rosuvastatin in Healthy Adults (MK-0616-039)

Active Not Recruiting
NCT06686615

A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia

Recruiting
NCT07088913Phase 1

A Study to Investigate the Effect of Capivasertib on the Pharmacokinetics of Oral Rosuvastatin in Healthy Participants

Completed
NCT04098003Phase 4

Investigation of the Gut Microbiome and Statin Response

Active Not Recruiting

Drug Details

Intervention Type
DRUG
Total Trials
409